Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04303741
What this trial is testing

A Phase II Trial of Camrelizumab in Combination With Apatinib and Eribulin in Patients With Advanced TNBC

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 46
Testing effectiveness (Phase 2)Study completedNCT03417895
What this trial is testing

SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy

Who this might be right for
Small-cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 59
Testing effectiveness (Phase 2)Looking for participantsNCT05983237
What this trial is testing

Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma

Who this might be right for
Melanoma
Jun Guo 50
Testing effectiveness (Phase 2)UnknownNCT04679480
What this trial is testing

Anti-PD1-antibody and Pulsed HHI for Advanced BCC

Who this might be right for
Basal Cell Carcinoma
Reinhard Dummer 20
Early research (Phase 1)Looking for participantsNCT06166888
What this trial is testing

AK131 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Akeso 130
Early research (Phase 1)Study completedNCT03790488
What this trial is testing

Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies

Who this might be right for
Cancer
Jounce Therapeutics, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT04646005
What this trial is testing

Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy

Who this might be right for
Cervical Cancer
Regeneron Pharmaceuticals 113
Large-scale testing (Phase 3)Active Not RecruitingNCT05652894
What this trial is testing

HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Taizhou Hanzhong biomedical co. LTD 190
Large-scale testing (Phase 3)Active Not RecruitingNCT06500026
What this trial is testing

A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung Cancer(PANKU-Lung03)

Who this might be right for
Small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 722
Testing effectiveness (Phase 2)UnknownNCT04126460
What this trial is testing

High-risk Recurrent or Second Primary HNSCC With PD-1 Antibody Adjuvant After Salvage Surgery(RePASS)

Who this might be right for
Head and Neck Cancer
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 41
Not applicableUnknownNCT04860076
What this trial is testing

Open-label, Uncontrolled, Non-Interventional, Retrospective Study to Evaluate Molecular Determinants of Outcome to the Immune Checkpoint Inhibitors (Anti-PD-1/Anti-PD-L1 Monoclonal Antibodies) Treatment for Solid Tumors

Who this might be right for
MelanomaLung Cancer
Asylia Diagnostics BV 400
Early research (Phase 1)Study completedNCT04047290
What this trial is testing

AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors

Who this might be right for
Neoplasms Malignant
Akesobio Australia Pty Ltd 80
Testing effectiveness (Phase 2)Study completedNCT05214482
What this trial is testing

AK112 in Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
Akeso 154
Testing effectiveness (Phase 2)Study completedNCT05505825
What this trial is testing

AK104 in Combination With Chiauranib in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
SCLC,Extensive Stage
Akeso 36
Early research (Phase 1)WithdrawnNCT05259397
What this trial is testing

PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Bladder Cancer
Pfizer
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06888648
What this trial is testing

Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer MetastaticPancreatic Cancer Non-resectable
Zhejiang University 30
Testing effectiveness (Phase 2)Study completedNCT03755440
What this trial is testing

PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients.

Who this might be right for
Gastric Cancer Stage IVEBV
Sun Yat-sen University 6
Large-scale testing (Phase 3)Study completedNCT03594747
What this trial is testing

Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
BeiGene 360
Early research (Phase 1)Ended earlyNCT03034304
What this trial is testing

A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
HRYZ Biotech Co. 105
Testing effectiveness (Phase 2)UnknownNCT05290935
What this trial is testing

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial

Who this might be right for
Recurrent Cervical CarcinomaPersistent Advanced Cervical CarcinomaChemotherapy+3 more
Lei Li 122
Next Page